文献速递泌尿系结石

氯噻酮与氢氯噻嗪对12小时与24小时尿钙排泄的影响

Effect of Chlorthalidone and Hydrochlorothiazide on 12-Hour vs 24-Hour Urinary Calcium Excretion.
PubMed 文献 · J Urol · 2025-04-07

在7例服用氯噻酮25 mg和10例服用氢氯噻嗪25 mg的患者中,进行12小时尿液收集,比较基线、晨服一周后和晚服一周后的尿钙排泄。氯噻酮在晨服和晚服时均降低12小时尿钙,氢氯噻嗪无论何时给药均未降低尿钙。作者认为长效氯噻酮是更优的结石预防药物,给药时间似乎不重要。

要点

  • 氯噻酮晨服降低尿钙从130±70 mg/g Cr至76±52 mg/g Cr(P<.02)。
  • 氯噻酮晚服降低尿钙至87±51 mg/g Cr,未达统计学显著。
  • 氢氯噻嗪25 mg无论晨服或晚服均未降低24小时尿钙。

核心结论

  • 作者认为长效且更有效的氯噻酮是预防结石的更优选择。
  • 给药时间似乎不重要,但晨服可能更有效应对晚餐后较高的钙排泄。
  • 最常用的噻嗪类氢氯噻嗪作用时间较短,常每日一次给药,但在此剂量下似乎不降低尿钙。

研究设计与样本

  • 在7例服用氯噻酮25 mg和10例服用氢氯噻嗪25 mg的患者中进行12小时尿液收集。
  • 参与者在基线、晨服药物一周后和晚服药物一周后完成尿液收集,均保持重复自选饮食。

主要发现

  • 氯噻酮晨服使尿钙从基线130±70 mg/g Cr降至76±52 mg/g Cr(P<.02)。
  • 氯噻酮晚服使尿钙降至87±51 mg/g Cr,未达统计学显著。
  • 氢氯噻嗪组24小时尿钙基线为124±38 mg/g Cr,晨服时为106±40 mg/g Cr,晚服时为117±54 mg/g Cr,无论给药时间均未降低尿钙。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Urine calcium excretion (UCa) is greater after dinner and urine volumes are lower. The result is higher urine calcium concentrations, which may confer greater risk of stone formation, at night. We considered whether nighttime administration-as compared with daytime administration-of thiazides would be more effective for stone prevention. MATERIALS AND METHODS: We performed 12-hour urine collections in 7 patients taking 25 mg of chlorthalidone (CTD) and 10 patients taking 25 mg of hydrochlorothiazide (HCTZ). Participants completed urine collections at baseline, again after a week of morning medication administration, and again after a week of evening administration, all on repeated self-selected diets. RESULTS: CTD reduced UCa for both 12-hour periods whether administered in the morning or in the evening: Morning dosing lowered urine calcium from 130 ± 70 mg/g creatinine (Cr) at baseline to 76 ± 52 mg/g Cr (P < .02); evening dosing lowered it to 87 ± 51 mg/g Cr, which was not significant. On the other hand, HCTZ did not reduce UCa regardless of the time of administration: Mean 24-hour UCa was 124 ± 38 mg/g Cr at baseline and 106 ± 40 mg/g Cr when HCTZ was given in the morning and 117 ± 54 mg/g Cr when given in the evening. CONCLUSIONS: We conclude that the long-acting and more effective CTD is a preferable agent for stone prevention. Time of administration does not seem to be important, although morning administration may more effectively address higher postdinner calcium excretion. The most commonly used thiazide (HCTZ) is shorter acting, frequently dosed once per day, but does not seem to reduce UCa at this dose.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Wollin DA, Fattah H, Asplin JR, et al. Effect of Chlorthalidone and Hydrochlorothiazide on 12-Hour vs 24-Hour Urinary Calcium Excretion. J Urol. 2025. PMID: 40194294. doi:10.1097/JU.0000000000004562

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。